A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study of the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study of the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Jun 2013

At a glance

  • Drugs Avanafil (Primary)
  • Indications Erectile dysfunction
  • Focus Registrational; Therapeutic Use
  • Acronyms REVIVE-RP
  • Most Recent Events

    • 26 Jun 2013 Avanafil approved for treatment of erectile dysfunction in the EU based on results of the RIVIVE, REVIVE-Diabetes and REVIVE-RP, according to a VIVUS media release.
    • 28 Mar 2012 Additional lead trial centres and investigator (Chuck Bowden) identified as reported by ClinicalTrials.gov.
    • 28 Mar 2012 Additional lead trial centres and investigator (Chuck Bowden) identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top